Loss of tolerance to nuclear antigens and multisystem tissue destruction is a hallmark of 20 systemic lupus erythematosus (SLE). Although the source of autoantigen in lupus 21 remains elusive, a compelling hypothetical source is dead cell debris that drives 22 autoimmune activation. Prior reports suggest that neutrophil extracellular traps (NETs) 23
to nucleic acids and the proteins to which these nucleic acids associate [1] . Loss of 38 tolerance to self-antigens results in immune activation and tissue destruction [1] . Although 39 the origin of autoantigens in SLE are not known, the liberation of antigenic contents from 40 dying cells is considered a likely culprit. 41 and quantify NETs, and what the triggers of and molecular pathways resulting in NET 48 formation are, as summarized in a recent consensus document [3] . These outstanding 49 issues in the NET field make it difficult to study the causative role for NETs in biological 50 processes and diseases. 51 52 Classical NET generation in humans and mice relies on NADPH oxidase-generated 53 reactive oxygen species (ROS) [4] [5] [6] . However, rapid NADPH oxidase-independent NET 54 formation, nuclear DNA externalization without concomitant cell lysis, and extrusion of 55 mitochondrial DNA have been described [3] . In addition to NADPH oxidase, 56 peptidylarginine deiminase 4 (PADI4) [7] [8] [9] [10] [11] [12] [13] , neutrophil elastase (ELANE) [10, [14] [15] [16] [17] , 57 4 and myeloperoxidase (MPO) [18, 19] have been identified as critical mediators of NET 58 formation. 59 60 It is a compelling paradigm that NETs could be a source of autoantigen and a downstream 61 mediator of end-organ damage in SLE. NETs are present in the peripheral blood, skin, 62 and kidneys of SLE patients and mice [2] . Early studies suggested that pharmacological 63 inhibition of PADI4 via pan-PAD inhibition with CL-and BB-CL-Amidine mildly improved 64 clinical manifestations of SLE in murine models [20, 21] . However, the NET hypothesis 65 has recently been challenged by studies that have either genetically deleted or 66 pharmacologically inhibited important NET mediators in multiple murine models of SLE. 67
Genetic deletion of critical NADPH oxidase complex components, required for the 68 neutrophil oxidative burst in addition to ROS-dependent NET formation, exacerbated SLE 69 in mice [22, 23] , an observation that also extends to humans [24, 25] To address this controversy, it is necessary to use additional genetic approaches to block 80 NET formation. We reason that while the case for NETs driving lupus could posit that one 81 or even more canonical members of the NET cascade would be dispensable specifically 82 in the case of lupus, it would be unlikely that multiple such molecules would all be 83 dispensable. Therefore, to further probe the hypothesis that NETs drive lupus, we decided 84 to genetically target the serine protease elane, since multiple studies both directly [10, 85 Anti-Sm, anti-nucleosome, anti-RNA, rheumatoid factor, total IgM, and IgG ELISAs were 169 performed as previously described [22, [38] [39] [40] [41] . Specific antibodies were detected with 170 alkaline phosphatase-conjugated goat anti-mouse IgG (Southern Biotech [1030-04]). The 171 monoclonal antibodies Y2, BWR4, 400tµ23, PL4-2 or PL2-3 (in-house) were used as 172 standards for the anti-Sm, anti-RNA, rheumatoid factor, and anti-nucleosome 173 measurements respectively.
10

Antinuclear Antibody Assay (ANA) 175
HEp-2 immunofluorescence assays were performed as previously described [22] . In brief, 176 serum was diluted 1/200 and then applied to HEp-2 slides (Antibodies Incorporated or 177 BD). Staining was detected using goat anti-mouse IgG FITC at 1:500 (Southern Biotech) 178
ANAs were scored on intensity of nuclear and cytoplasmic staining on a scale of 0-3 and 179
for the presence or absence of mitotic chromatin using wide-field fluorescence 180 Elane deficiency had no effect on nephritis or dermatitis 198
No differences in urine protein were detected across elane genotypes in either male or 199 female cohorts ( Fig 1A) . Elane deficiency resulted in no significant alterations in 200 glomerulonephritis or interstitial nephritis ( Fig 1B) . No statistically significant differences 201 in dermatitis were detected among the different elane genotypes in either cohort ( Fig 1C) . 202
Similarly, elane genotype did not alter splenomegaly or lymphadenopathy ( Fig 1D) . Elane genotype has no impact on loss of tolerance and the anti-self response 215
To determine the effect of ELANE on the autoantibody response in SLE, we characterized 216 the ANA patterns in elane-sufficient and -deficient MRL.Fas lpr mice. No differences were 217 identified in the dominant ANA pattern or staining intensity across groups (Supplemental 218 Fig 1A) . ELANE deficiency did not alter anti-chromatin autoantibodies as no differences 219 in mitotic chromatin staining were observed (Supplemental Fig 1B) . Concordant with 220 these data, we did not detect any changes in anti-RNA antibody (Fig 2A) , anti-Sm 221 antibody ( Fig 2B) , anti-nucleosome antibody ( Fig 2C) , and rheumatoid factor ( Fig 2D) Elane-genotype did not affect the percentages of CD19 + B cells ( Fig 3D) or CD19 low-int 238 CD44 + CD138 + intracellular k high AFCs (Fig 2E, right panel) . Similarly, there were no 239 statistically significant differences in total kappa Ig AFC ELISpots (Fig 2E, left panel) . 240
Wild-type female mice had a higher number of IgG1 AFCs compared to their elane-241 deficient MRL.Fas lpr counterparts (Fig 2F, p=0.0141 ). This finding is unlikely to be 242 biologically significant, as these data were not mirrored across gender. No differences 243 were identified in IgG2a and IgM AFC ELISpots amongst the groups (Fig 2G & H) . 244
245
ELANE deficiency did not substantially change the myeloid compartment 246
Elane genotype had only a minor impact on the myeloid compartment in MRL.Fas lpr mice. 247
The percentages of CD11b + Ly6G + (Fig 3A, 
left panel) bone marrow (BM) neutrophils and 248
CD11b + F4/80 + Gr1 low-int BM macrophages (Fig 3B, right panel) were not statistically 249 different among the groups. Additionally, no changes in CD11b + Ly6G + (Fig 3B, left panel) 250 splenic neutrophils or CD11b + F4/80 + Gr1 low-int ( Fig 3B, right panel) splenic macrophages 251 were identified across elane genotypes. Female wild-type mice had a greater percentage 252 of splenic cDCs compared to the elane -/group (Fig 3C, left panel, p=0 .0039). No 253 differences in the percentages of CD19 -BST2 + SiglecH + pDCs (Fig 3C, right panel) were 254 identified among elane genotypes. 
ELANE deficiency had a modest impact on the lymphoid compartment 270
Elane deficiency did not substantially impact the lymphoid compartment. All genotypes 271 exhibited indistinguishable total percentages of TCRb + T cells ( Fig 3D) . The percentages 272 of CD4 + T cells were elevated in female knock-out mice (Fig 3E, left panel, p=0 .0429) 273 while CD4 + CD44 + CD62Lactivated T cells were elevated in male wild-type mice (Fig 3E,  274 right panel, p=0.0348). The percentages of CD8 + T cells and CD8 + CD44 + CD62L -275 activated T cells were similar amongst wild-type and elane-deficient mice ( Fig 3F) . The data from the genetic study presented here in a relevant murine model of lupus does 280 not support the hypothesis that ELANE, and by extension ELANE-dependent NET 281 generation and neutrophil effector function, alters immune system composition or 282 pathology in SLE. This conclusion is reinforced by prior work from our group and that of 283 others targeting PADI4 in SLE and nephritis models that yielded similar results [23, 26] . 284
Moreover, NADPH deficiency exacerbates SLE in mice and humans. It remains unknown 285 whether this phenotype is neutrophil or NET dependent as NADPH oxidase is implicated 286 in immunoregulatory functions in both the myeloid and lymphoid compartments [43] . 287
288
In humans, elane mutations are generally associated with congenital neutropenias but 289 not systemic autoimmunity [44] . However, a recent study identified a patient with a novel 290 loss of function polymorphism (G210R) in exon 5 of elane that did not confer congenital 291 neutropenia, but the patient did exhibit inflammatory arthritis and recurrent parvovirus 292 argued that the type of NET generation seen in SLE proceeds independently of the protein 356 in question, it seems unlikely that the putative type of NET generation that is hypothesized 357 to critically drive lupus is independent of three of the major pathways documented to be 358 important for NET formation. This point, which is punctuated by the current data, along 359 with the lack of a role for neutrophils per se in driving lupus, heralds a juncture at which 360 the field should seriously reevaluate whether the "NETs drive lupus" hypothesis remains 361 valid and whether blocking NET formation or neutrophil function makes sense as a 362 therapeutic strategy. In contrast, multiple studies have shown regulatory roles in various 363 systems for CYBB, and to an extent PAD4 and MPO, such that disease is exacerbated 364 in their absence [22, 23, 26, 27, 59] . We would thus posit that neutrophils and their effector 365 mechanisms, such as NET generation, may have evolved to protect us from autoimmune 366 diseases, rather than function as vectors to promote them. 367 368 19 Acknowledgements 369 370
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